2020 Drugs of Abuse Testing Market for 12 Assays - Supplier Shares & Strategies, Volume & Sales Segment Forecasts & Profiles of Leading Competitors - ResearchAndMarkets.com

This new 318-page report from the author contains 68 tables and provides analysis of the global drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.

Metadata
Provider: 
Business Wire, Inc.Business Wire, Inc.
Retrieved on: 
Thursday, February 6, 2020
Information
Tags: 
Health, General Health, Natural sciences, Physical sciences, Chemistry, Assay, Biochemistry, Titration, Market segmentation, Forecasting, Drug test
⚠generated by AI ↴
Summary
Key Points: 
  • This new 318-page report from the author contains 68 tables and provides analysis of the global drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.
  • The report provides test volume and sales forecasts by country and market segment for the following assays:
    During the next decade, the abused drug testing market will undergo significant transformation.
  • Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology.
  • The study explores future trends in the U.S., five major European countries and Japan; and provides test volume and sales forecasts by country, market segment and individual assay.


The "2020 Drugs of Abuse Testing Market for 12 Assays: US, Europe, Japan - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Profiles of Leading Competitors" report has been added to ResearchAndMarkets.com's offering.

This new 318-page report from the author contains 68 tables and provides analysis of the global drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.

The report provides test volume and sales forecasts by country and market segment for the following assays:

Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxphene

During the next decade, the abused drug testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.

This unique study is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends in the U.S., five major European countries and Japan; and provides test volume and sales forecasts by country, market segment and individual assay.

Companies Mentioned

  • Abbott Laboratories
  • Agilent Technologies
  • Beckman Coulter/Danaher
  • bioMerieux
  • Bio-Rad
  • DiaSorin
  • Eiken Chemical
  • Fujirebio
  • Grifols
  • Instrumentation Laboratory/Werfen
  • Kyowa Medex
  • Ortho-Clinical Diagnostics
  • PerkinElmer
  • Quest Diagnostics
  • Roche
  • Siemens Healthineers
  • Sysmex
  • Thermo Fisher
  • Tosoh
  • Wako

For more information about this report visit https://www.researchandmarkets.com/r/8mryb2

Copyright: 
Copyright Business Wire 2020